| Primary information |
|---|
| ID | 13450 |
| Uniprot ID | B0VXV8 |
| Description | Bradykinin potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into- Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide-1) (BPP-1); Bradykinin-potentiating peptide-2 (BPP-2); Bradykinin inhibitor peptide homolog; C-type natriuretic peptide (CNP)] |
| Organism | Sistrurus catenatus edwardsii |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria (diapsids); Lepidosauria (lepidosaurs); Squamata (squamates); Bifurcata (split-tongued squamates); Unidentata; Episquamata; Toxicofera; Serpentes (snakes); Colubroidea; Viperidae; Crotalinae (pit vipers); Sistrurus; Sistrurus catenatus (massasauga); Sistrurus |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | In the N-terminal section; belongs to the bradykinin-potentiating peptide family. |
| Tissue Specificity | Venom gland. |
| Post Translational Modification | NA |
| Function | [Bradykinin-potentiating peptide 10c]- inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain. May also potentiate the hypotensive effects of bradykinin. |
| Length | 201 |
| Molecular Weight | 20 |
| Name | NA |
| Sequence | NA |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|